THE SEQUELAE OF GIANT CELL MYOCARDITIS AND ITS RAPID PROGRESSION

Omar Safdar(Thomas Jefferson University), Ilya Danelich(AstraZeneca (South Korea)), Nicholas Ruggiero(Thomas Jefferson University), Matthew DeCaro(Thomas Jefferson University Hospital), Arnold J. Greenspon(Thomas Jefferson University Hospital), Ataul Qureshi(Thomas Jefferson University), Alec Vishnevsky(Thomas Jefferson University), René Alvarez(Thomas Jefferson University), Preethi Pirlamarla(Thomas Jefferson University)
Journal of the American College of Cardiology
March 1, 2020
10.1016/s0735-1097(20)33997-8
Cited by 0

Related Papers

Time to Anticoagulation Reversal and Outcomes After Intracerebral Hemorrhage
|JAMA Neurology|2024|88
Practical Management of Postoperative Atrial Fibrillation after Noncardiac Surgery
|Journal of the American College of Surgeons|2014|73
Safety of Nonsteroidal Antiinflammatory Drugs in Patients with Cardiovascular Disease
|Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy|2015|55
Role of clinical pharmacists and pharmacy support personnel in transitions of care
|JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY|2020|40
Impact of the Pharmacy Practice Model Initiative on Clinical Pharmacy Specialist Practice
|Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy|2016|29